Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 million in Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $1.9 million, up 2007.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 2007.95% YoY), and the FY2025 annual result was $1.7 million, up 1941.18% from the prior year.
• Non-Current Deferred Tax Liability grew to $1.9 million in Q1 2026 per LMAT's latest filing, from $1.7 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $2.1 million in Q3 2025 and troughed at $60000.0 in Q3 2022.
• A 5-year average of $403117.6 and a median of $88000.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2026: Non-Current Deferred Tax Liability sank 50.82% in 2022, then soared 2007.95% in 2026.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $69000.0 in 2022, then surged by 55.07% to $107000.0 in 2023, then declined by 20.56% to $85000.0 in 2024, then surged by 1941.18% to $1.7 million in 2025, then gained by 6.92% to $1.9 million in 2026.
• Business Quant data shows LMAT's Non-Current Deferred Tax Liability at $1.9 million in Q1 2026, $1.7 million in Q4 2025, and $2.1 million in Q3 2025.